Tyrosine kinase inhibitors in patients with advanced anaplastic thyroid cancer: an effective analysis based on real-world retrospective studies.

MLA

Kuang, Bo-Hua, et al. “Tyrosine Kinase Inhibitors in Patients with Advanced Anaplastic Thyroid Cancer: An Effective Analysis Based on Real-World Retrospective Studies.” Frontiers in Endocrinology, vol. 15, Feb. 2024, p. 1345203. EBSCOhost, https://doi.org/10.3389/fendo.2024.1345203.

APA

Kuang, B.-H., Zhang, W.-X., Lin, G.-H., Fu, C., Cao, R.-B., & Wang, B.-C. (2024). Tyrosine kinase inhibitors in patients with advanced anaplastic thyroid cancer: an effective analysis based on real-world retrospective studies. Frontiers in Endocrinology, 15, 1345203. https://doi.org/10.3389/fendo.2024.1345203

Chicago

Kuang, Bo-Hua, Wen-Xuan Zhang, Guo-He Lin, Chen Fu, Ru-Bo Cao, and Bi-Cheng Wang. 2024. “Tyrosine Kinase Inhibitors in Patients with Advanced Anaplastic Thyroid Cancer: An Effective Analysis Based on Real-World Retrospective Studies.” Frontiers in Endocrinology 15 (February): 1345203. doi:10.3389/fendo.2024.1345203.